Skip to main content

Advertisement

ADVERTISEMENT

Volume 33 - Issue 4 - April, 2021

Mitral Valve Surgery After Failed MitraClip: A Single-Center Experience
04/01/2021

Florian Rader, MD, MSc1;  Robert J. Siegel, MD1;  Nir Flint, MD1,2;  Harjit Minhas, BS3; Yehezkel G. Shmueli, MD1;  Takahiro Shiota, MD1;  Alfredo Trento, MD4

Florian Rader, MD, MSc1;  Robert J. S...
This study evaluates candidacy for surgical mitral valve repair of recurrent mitral regurgitation after failed MitraClip implantation.
This study evaluates candidacy for surgical mitral valve repair of recurrent mitral regurgitation after failed MitraClip implantation.
This study evaluates candidacy...
04/01/2021
Journal of Invasive Cardiology
A Novel Risk Score to Predict  One-Year Mortality in Patients Undergoing Complex High-Risk Indicated Percutaneous Coronary Intervention (CHIP-PCI)
04/01/2021

Sorin J. Brener, MD;  Gregory J. Cunn, MD;  Pankil H. Desai, MD;  Mouzamjha Faroqui, MD;  Le Dung Ha, MD;  Garima Handa, MD;  Issa Kutkut, MD; Adnan S. Raza, MD;  Terrence J. Sacchi, MD

Sorin J. Brener, MD;  Gregory J. Cunn...
Our aim was to identify patients undergoing complex, high-risk indicated percutaneous coronary intervention (CHIP-PCI) and compare their outcomes with non-CHIP patients. We created a CHIP score to risk stratify these patients.
Our aim was to identify patients undergoing complex, high-risk indicated percutaneous coronary intervention (CHIP-PCI) and compare their outcomes with non-CHIP patients. We created a CHIP score to risk stratify these patients.
Our aim was to identify patients...
04/01/2021
Journal of Invasive Cardiology
Evaluation of a Real-World In-Hospital Antiplatelet-Switching Strategy Following Coronary Interventions: The SWITCH Study
04/01/2021

Antoine E. Soueid, MD, PharmD, JD1;  Ibrahim Kassas, MD2;  Jeffrey Rade, MD1; Nikolaos Kakouros, MBBS, MD(Res), PhD1

Antoine E. Soueid, MD, PharmD, JD1;  ...
Newer antiplatelet therapy agents are reliable and have a fast onset of action, but have significantly higher cost, leading to compliance concerns. We adopted and evaluated an acute agent-switching strategy, using prasugrel or ticagrelor for...
Newer antiplatelet therapy agents are reliable and have a fast onset of action, but have significantly higher cost, leading to compliance concerns. We adopted and evaluated an acute agent-switching strategy, using prasugrel or ticagrelor for...
Newer antiplatelet therapy...
04/01/2021
Journal of Invasive Cardiology
Complex Bifurcation Lesions: Randomized Comparison of Modified-T Stenting vs Reconstruction With  Self-Expanding Stent and Bioresorbable Scaffold: COBRA II
04/01/2021

Johan Bennett, MD, PhD1,2;  Keir McCutcheon, MD, PhD1,2;  Maarten Vanhaverbeke, MD, PhD1;  Ruben Pauwels, MD1;  Tom Adriaenssens, MD, PhD1,2;  Peter Sinnaeve, MD, PhD1,2;
Walter Desmet, MD, PhD1,2;  Christophe Dubois, MD, PhD1,2

Johan Bennett, MD, PhD1,2;  Keir McCu...
We evaluate the role of a double bioresorbable vascular scaffold (BVS) strategy in coronary bifurcations, alone or in combination with a dedicated bifurcation device.
We evaluate the role of a double bioresorbable vascular scaffold (BVS) strategy in coronary bifurcations, alone or in combination with a dedicated bifurcation device.
We evaluate the role of a double...
04/01/2021
Journal of Invasive Cardiology
Characteristics and Outcomes of Patients Ineligible for Transcatheter Mitral Valve Replacement (TMVR): Implications for Future Device Innovation
04/01/2021

Sebastian Ludwig, MD1;  Benedikt Koell, MD1;  Roya Sedighian, MD1;  Jessica Weimann, MD1;  Niklas Schofer, MD1;  Andreas Schäfer, MD2;  Lisa Voigtländer, MD1;  Lara Waldschmidt, MD1;  Johannes Schirmer, MD2;  Moritz Seiffert, MD1;  Simon Pecha, MD2;  Dirk Westermann, MD1;  Hermann Reichenspurner, MD2;  Stefan Blankenberg, MD1;  Edith Lubos, MD1;  Lenard Conradi, MD2;  Daniel Kalbacher, MD1

Sebastian Ludwig, MD1;  Benedikt Koel...
Due to high rates of transcatheter mitral valve replacement (TMVR) screening failure, a substantial proportion of patients with severe mitral regurgitation (MR) remain on optimal medical treatment only. This study aimed to assess...
Due to high rates of transcatheter mitral valve replacement (TMVR) screening failure, a substantial proportion of patients with severe mitral regurgitation (MR) remain on optimal medical treatment only. This study aimed to assess...
Due to high rates of...
04/01/2021
Journal of Invasive Cardiology
Clinical Impact of Crossover Techniques for Primary Access Hemostasis in Transfemoral Transcatheter Aortic Valve Replacement Procedures
04/01/2021

Lucía Junquera, MD1;  Marina Urena, MD2;  Azeem Latib, MD3,4;  Antonio Muñoz-Garcia, MD5;  Luis Nombela-Franco, MD6;  Benjamin Faurie, MD7;  Alberto Alperi, MD8;  Vicenç Serra, MD9;  Ander Regueiro, MD10;  Quentin Fisher, MD2;  Dominique Himbert, MD2;  Antonio Mangieri, MD3,11;  Antonio Colombo, MD3,11;  Erika Muñoz García, MD5;  Rafael Vera Urquiza, MD6; Pilar Jiménez-Quevedo, MD6;  Isaac Pascual, MD8;  Bruno Garcia del Blanco, MD9; Manel Sabaté, MD10;  Siamak Mohammadi, MD1;  Afonso B. Freitas-Ferraz, MD1; Guillem Muntané-Carol, MD1;  Thomas Couture, MS1;  Jean-Michel Paradis, MD1; Melanie Côté, MD1;  Josep Rodés-Cabau, MD1

Lucía Junquera, MD1;  Marina Urena, M...
Our objective was to determine the occurrence of vascular complications following transfemoral transcatheter aortic valve replacement with new-generation devices according to the use of a crossover technique.
Our objective was to determine the occurrence of vascular complications following transfemoral transcatheter aortic valve replacement with new-generation devices according to the use of a crossover technique.
Our objective was to determine...
04/01/2021
Journal of Invasive Cardiology

Feature

The Utility of Peripheral Intravascular Lithotripsy in Calcific Coronary Artery Disease: A Case Series
BRIEF COMMUNICATION
04/01/2021

Brett B. Yarusi, MD1;  Vikrant S. Jagadeesan, MD2;  Arif Jivan, MD, PhD2;
Erin D. Unger, MD2;  Lowie M.R. Van Assche, MD2;  Tim S. Provias, MD, MPH2; James D. Flaherty, MD2;  Keith H. Benzuly, MD2;  Daniel R. Schimmel, MD, MS2

Brett B. Yarusi, MD1;  Vikrant S. Jag...
We performed a retrospective review of patients who were excluded from preapproval trials of coronary IVL and underwent CAC modification with the off-label use of a peripheral IVL system.
We performed a retrospective review of patients who were excluded from preapproval trials of coronary IVL and underwent CAC modification with the off-label use of a peripheral IVL system.
We performed a retrospective...
04/01/2021
Journal of Invasive Cardiology
Intravascular Ultrasound for Pulmonary Vein Stenosis Interventions in Congenital Heart Disease
Original Contribution
04/01/2021

Samantha A. Kops, MD1;  Danielle Strah, MD1;  Kwan S. Lee, MD2;  Michael D. Seckeler, MD, MSc3

Samantha A. Kops, MD1;  Danielle Stra...
The goal of this study was to determine the utility of intravascular ultrasound for patients with congenital heart disease and pulmonary vein stenosis.
The goal of this study was to determine the utility of intravascular ultrasound for patients with congenital heart disease and pulmonary vein stenosis.
The goal of this study was to...
04/01/2021
Journal of Invasive Cardiology
Feasibility of Quantitative Flow Ratio in Adult Patients With Anomalous Aortic Origin of the Coronary Artery With  5 Years of Clinical Follow-up
Original Contribution
04/01/2021

Julien Adjedj, MD, PhD1,2*;  Fabien Hyafil, MD3*;  Farhang Aminfar, MD2*;  Xavier Halna du Fretay, MD4,5;  Fabien Picard, MD, MSc6;  Patrick Dupouy, MD7;Jean-Michel Juliard, MD5;  Olivier Muller, MD, PhD2;  William Wijns, MD, PhD8; Pierre Aubry, MD5; on behalf of the ANOCOR Investigators 

Julien Adjedj, MD, PhD1,2*;  Fabien H...
Anomalous origin of the right coronary artery (ARCA) represents the most common form of abnormal coronary origin and may potentially increase the risk for sudden cardiac death. We aimed to evaluate the feasibility of QFR analysis in patients...
Anomalous origin of the right coronary artery (ARCA) represents the most common form of abnormal coronary origin and may potentially increase the risk for sudden cardiac death. We aimed to evaluate the feasibility of QFR analysis in patients...
Anomalous origin of the right...
04/01/2021
Journal of Invasive Cardiology
Predictors of Hemodynamic Response to Intra-Aortic Balloon Pump Therapy in Patients With Acute Decompensated Heart Failure and Cardiogenic Shock
Original Contribution
04/01/2021

Athena L. Huang, MD1;  Justin A. Fried, MD1;  Waqas Malick, MD3;  Veli Topkara, MD, MS1;  Ersilia M. DeFilippis, MD1;  Jennifer Haythe, MD1;  Maryjane Farr, MD, MS1;  Melana Yuzefpolskaya, MD1;  Paolo C. Colombo, MD1; Koji Takeda, MD, PhD2;  E. Wilson Grandin, MD, MPH4;  Ajay J. Kirtane, MD, SM1; Duane Pinto, MD4;  A. Reshad Garan, MD, MS4

Athena L. Huang, MD1;  Justin A. Frie...
There is renewed interest in intra-aortic balloon pump (IABP) use in chronic systolic heart failure patients with acute decompensation and cardiogenic shock. We sought to identify predictors of early IABP response to guide optimal use in this...
There is renewed interest in intra-aortic balloon pump (IABP) use in chronic systolic heart failure patients with acute decompensation and cardiogenic shock. We sought to identify predictors of early IABP response to guide optimal use in this...
There is renewed interest in...
04/01/2021
Journal of Invasive Cardiology

Advertisement

Advertisement

Advertisement